在两个独立队列中开发并验证慢性胰腺炎预后评分
研究前瞻性纳入91例慢性胰腺炎患者,分析临床、实验室和影像数据与12个月内再入院次数和住院天数的相关性,建立3阶段慢性胰腺炎预后评分(COPPS),并在129例独立受试者中验证其预测强度。COPPS与再入院次数和住院天数相关,与Cambridge分类系统不相关。
要点
- COPPS由疼痛数字评分、糖化血红蛋白A1c、C反应蛋白、体重指数和血小板计数构成。
- COPPS中位8.9分(范围5-14),分A(5-6分)、B(7-9分)、C(10-15分)三阶段。
- 开发队列中COPPS与再入院次数相关0.39(P<.01),与住院天数相关0.33(P<.01)。
核心结论
- 研究开发并验证了一种易于使用的动态多变量评分系统COPPS,类似肝硬化Child-Pugh评分,可客观监测慢性胰腺炎患者,确定再入院风险和潜在住院时间。
研究设计与样本
- 前瞻性研究纳入91例慢性胰腺炎患者,数据来自欧洲学术中心2011年1月至2014年4月就诊患者。
- 预测强度在来自2个前瞻性数据库的129例独立受试者中验证。
主要发现
- 开发队列平均入院次数1.9次(95%CI 1.39-2.44),住院天数15.2天(95%CI 10.76-19.71);验证队列住院天数10.9天(95%CI 7.54-14.30)(P=.08)。
- 基于双变量相关性,疼痛数字评分、糖化血红蛋白A1c水平、C反应蛋白水平、体重指数和血小板计数用于开发COPPS系统。
- 患者COPPS中位8.9分(范围5-14),系统准确区分疾病严重程度阶段(从低到高):A(5-6分)、B(7-9分)、C(10-15分)。
- 开发队列Pearson相关分析中,COPPS与入院次数相关(0.39;P<.01),与住院天数相关(0.33;P<.01)。
- 验证集中相关性得到验证(Pearson相关值0.36和0.44;P<.01);COPPS与Cambridge分类系统结果不相关。
临床怎么用
- 作者认为COPPS可客观监测慢性胰腺炎患者,确定再入院风险和潜在住院时间。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The clinical course of chronic pancreatitis is unpredictable. There is no model to assess disease severity or progression or predict patient outcomes. METHODS: We performed a prospective study of 91 patients with chronic pancreatitis; data were collected from patients seen at academic centers in Europe from January 2011 through April 2014. We analyzed correlations between clinical, laboratory, and imaging data with number of hospital readmissions and in-hospital days over the next 12 months; the parameters with the highest degree of correlation were used to develop a 3-stage chronic pancreatitis prognosis score (COPPS). The predictive strength was validated in 129 independent subjects identified from 2 prospective databases. RESULTS: The mean number of hospital admissions was 1.9 (95% confidence interval [CI], 1.39-2.44) and 15.2 for hospital days (95% CI, 10.76-19.71) for the development cohort and 10.9 for the validation cohort (95% CI, 7.54-14.30) (P = .08). Based on bivariate correlations, pain (numeric rating scale), level of glycated hemoglobin A1c, level of C-reactive protein, body mass index, and platelet count were used to develop the COPPS system. The patients' median COPPS was 8.9 points (range, 5-14). The system accurately discriminated stages of disease severity (low to high): A (5-6 points), B (7-9), and C (10-15). In Pearson correlation analysis of the development cohort, the COPPS correlated with hospital admissions (0.39; P < .01) and number of hospital days (0.33; P < .01). The correlation was validated in the validation set (Pearson correlation values of 0.36 and 0.44; P < .01). COPPS did not correlate with results from the Cambridge classification system. CONCLUSIONS: We developed and validated an easy to use dynamic multivariate scoring system, similar to the Child-Pugh-Score for liver cirrhosis. The COPPS allows objective monitoring of patients with chronic pancreatitis, determining risk for readmission to hospital and potential length of hospital stay.
引用
- Beyer G, Mahajan UM, Budde C, et al. Development and Validation of a Chronic Pancreatitis Prognosis Score in 2 Independent Cohorts. Gastroenterology. 2017. PMID: 28918191. doi:10.1053/j.gastro.2017.08.073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。